Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
RNXT	RENOVORX INC	$51.90M	-145.60%	-109.80%	-128.13%	3,950.20%	0.28	5.74	84.40%	-621.70%	-621.71%
BIAF	BIOAFFINITY TECHNOLOGIES INC	$1.96M	-257.30%	-159.50%	-306.46%	-1,731.40%	1.02	1.44	34.60%	-257.30%	-256.47%
GHRS	GH RESEARCH PLC	$1.29B	-20.90%	-20.10%	-17.24%	-220.00%	0.04	28.70	N/A	N/A	N/A
GNPX	GENPREX INC	$2.06M	-163.10%	-129.00%	-111.51%	4,732.10%	0.16	6.77	N/A	N/A	N/A
OBX	OBSIDIAN THERAPEUTICS INC	$740.66M	N/A	N/A	N/A	N/A	-0.07	2.30	N/A	N/A	N/A
SPTX	SEAPORT THERAPEUTICS INC	$860.77M	N/A	N/A	N/A	N/A	0.05	18.00	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$307.52M	-53.90%	-48.20%	-25.65%	-97.90%	0.06	24.16	N/A	N/A	N/A
SSII	SS INNOVATIONS INTERNATIONAL INC	$510.98M	-26.80%	-15.00%	-10.79%	-12.90%	0.82	2.24	47.60%	-23.70%	-13.40%
DMRA	DAMORA THERAPEUTICS INC	$1.15B	-82.40%	-77.90%	-50.86%	1,686.80%	0.05	19.73	N/A	N/A	N/A
VBIO	VALION BIO INC	$1.38M	-199.00%	-69.10%	-58.67%	-71.20%	4.85	1.11	66.70%	12,019.20%	11,067.31%
ATR	APTARGROUP INC	$7.58B	13.60%	7.00%	12.95%	18.80%	0.95	1.61	36.10%	9.20%	13.16%
CVRX	CVRX INC	$36.23M	-152.40%	-50.90%	-56.61%	-64.80%	3.63	8.05	86.90%	-84.90%	-75.09%
LYEL	LYELL IMMUNOPHARMA INC	$184.03M	-91.60%	-70.50%	-91.59%	-93.70%	0.33	5.36	100.00%	-993,908.00%	-993,908.00%
EWTX	EDGEWISE THERAPEUTICS INC	$3.94B	-39.00%	-37.00%	-43.76%	-43.00%	0.07	16.24	N/A	N/A	N/A
RXST	RXSIGHT INC	$188.42M	-17.40%	-14.70%	-17.20%	-17.30%	0.34	4.07	77.50%	-36.80%	-36.70%
TLSI	TRISALUS LIFE SCIENCES INC	$246.30M	N/A	-114.40%	-43.61%	-59.10%	8.53	5.35	85.80%	-130.20%	-49.61%
VTVT	VTV THERAPEUTICS INC	$111.62M	-6.30%	-5.10%	-5.90%	71.10%	0.11	12.48	100.00%	-12.90%	-12.89%
IRON	DISC MEDICINE INC	$2.17B	-37.20%	-33.70%	-34.34%	-38.20%	0.14	24.14	N/A	N/A	N/A
GENB	GENERATE BIOMEDICINES INC	$1.57B	N/A	N/A	N/A	N/A	0.23	8.30	N/A	N/A	N/A
PTN	PALATIN TECHNOLOGIES INC	$14.59M	-115.00%	-69.40%	-123.98%	1,125.00%	0.28	4.61	100.00%	-63.50%	-63.49%
RDY	DR REDDYS LABORATORIES LTD	$10.66B	12.10%	8.00%	14.31%	18.40%	0.53	1.80	52.80%	12.80%	17.54%
QSI	QUANTUM-SI INC	$308.63M	-47.10%	-43.20%	-54.29%	-52.70%	0.07	9.97	35.00%	-6,138.30%	-6,144.17%
PALI	PALISADE BIO INC	$255.31M	-33.50%	-31.80%	-26.16%	956.50%	0.05	24.26	100.00%	-6,388.20%	-6,386.60%
KLRS	KALARIS THERAPEUTICS INC	$53.09M	-71.70%	-42.90%	-48.75%	-107.00%	0.73	10.98	N/A	N/A	N/A
BIVI	BIOVIE INC	$9.05M	-126.30%	-109.10%	-210.96%	-2,942.30%	0.39	3.59	N/A	N/A	N/A
ENTA	ENANTA PHARMACEUTICALS INC	$335.52M	-61.80%	-20.70%	-20.69%	-18.00%	1.94	3.76	100.00%	-96.90%	-76.95%
CGC	CANOPY GROWTH CORP	$322.35M	-32.80%	-21.50%	-25.22%	-32.50%	0.60	3.04	25.20%	-80.40%	-80.49%
SGP	SPYGLASS PHARMA INC	$800.08M	N/A	N/A	N/A	N/A	0.05	25.06	N/A	N/A	N/A
ACET	ADICET BIO INC	$47.84M	-74.90%	-60.90%	-75.87%	-82.00%	0.23	6.71	N/A	N/A	N/A
PLRZ	POLYRIZON LTD	$20.70M	-21.40%	-21.00%	-21.25%	-77.10%	0.02	36.37	N/A	N/A	N/A
IDYA	IDEAYA BIOSCIENCES INC	$3.31B	-16.50%	-15.10%	-14.26%	-19.30%	0.09	10.45	100.00%	-74.80%	-74.75%
DNLI	DENALI THERAPEUTICS INC	$2.94B	-55.30%	-44.20%	-47.88%	-53.60%	0.39	8.37	97.40%	-14,191.20%	-14,188.37%
DMAC	DIAMEDICA THERAPEUTICS INC	$421.70M	-77.80%	-69.50%	-97.80%	-90.80%	0.17	6.72	N/A	N/A	N/A
MOH	MOLINA HEALTHCARE INC	$10.94B	-0.20%	0.00%	2.44%	3.80%	2.84	1.68	8.00%	0.00%	0.46%
NNVC	NANOVIRICIDES INC	$33.69M	-91.10%	-80.70%	-94.65%	-145.80%	0.14	2.66	N/A	N/A	N/A
GYRE	GYRE THERAPEUTICS INC	$748.23M	-17.70%	-10.80%	-8.18%	-12.90%	0.32	4.26	94.30%	-15.50%	-11.69%
MBX	MBX BIOSCIENCES INC	$2.36B	-26.00%	-24.90%	-25.30%	-34.30%	0.06	18.08	N/A	N/A	N/A
CBUS	CIBUS INC	$107.76M	-320.60%	-30.90%	-20.45%	-21.10%	20.18	1.62	100.00%	-2,258.90%	-1,406.69%
ERAS	ERASCA INC	$5.17B	-80.40%	-67.10%	-71.54%	-74.30%	0.20	8.29	N/A	N/A	N/A
AKTX	AKARI THERAPEUTICS PLC	$0.00	-147.40%	-74.70%	-128.95%	259.70%	1.08	0.60	N/A	N/A	N/A
PMVP	PMV PHARMACEUTICALS INC	$72.17M	-78.10%	-70.10%	-105.17%	-114.60%	0.15	7.70	N/A	N/A	N/A
CGTX	COGNITION THERAPEUTICS INC	$76.27M	-50.20%	-40.20%	-50.12%	1,019.40%	0.18	7.03	N/A	N/A	N/A
ZCMD	ZHONGCHAO INC	$26.99k	-32.00%	-25.20%	-27.69%	-40.30%	0.08	11.11	45.00%	-55.50%	-55.07%
KMTS	KESTRA MEDICAL TECHNOLOGIES LTD	$1.61B	-64.20%	-45.00%	-47.48%	-78.30%	0.56	4.69	53.90%	-140.40%	-133.05%
ICCM	ICECURE MEDICAL LTD	$2.98M	-174.30%	-112.60%	-140.33%	-1,210.30%	0.49	2.88	36.10%	-427.70%	-423.69%
ELAB	PMGC HOLDINGS INC	$2.40M	-118.10%	-59.70%	-57.22%	-304.60%	1.19	1.36	31.10%	-523.00%	-471.21%
FTH	FAETH THERAPEUTICS INC	$555.83M	-1,012.20%	-175.70%	-108.79%	-356.40%	0.06	19.69	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$189.23M	-57.60%	-46.50%	-59.44%	-56.60%	0.28	10.89	100.00%	-3,537.70%	-3,520.25%
CLNN	CLENE INC	$43.56M	N/A	-185.60%	-201.42%	-129.80%	-1.93	3.07	70.10%	-20,059.90%	-18,597.46%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$96.52M	-38.80%	-30.50%	-38.97%	-37.80%	0.30	7.28	N/A	N/A	N/A
GLUE	MONTE ROSA THERAPEUTICS INC	$843.75M	-43.30%	-27.60%	-25.97%	-40.30%	0.42	10.58	100.00%	-560.90%	-570.80%
IMMX	IMMIX BIOPHARMA INC	$621.68M	-38.40%	-34.70%	-17.36%	-1,845.60%	0.05	25.13	N/A	N/A	N/A
LGVN	LONGEVERON INC	$6.85M	-223.20%	-150.20%	-209.96%	-12,453.10%	0.49	2.63	69.80%	-1,977.60%	-1,977.59%
NUVB	NUVATION BIO INC	$1.66B	-49.70%	-23.50%	-18.72%	-19.00%	1.93	8.37	88.20%	-88.20%	-72.49%
CAMP	CAMP4 THERAPEUTICS CORP	$215.24M	-314.10%	-106.40%	-144.37%	2,371.30%	-135.82	4.70	100.00%	-2,543.70%	-2,543.74%
KARD	KARDIGAN INC	$1.21B	N/A	N/A	N/A	N/A	0.17	8.72	N/A	N/A	N/A
ACRS	ACLARIS THERAPEUTICS INC	$510.78M	-61.60%	-42.40%	-50.01%	-59.20%	0.44	3.46	12.90%	-921.50%	-921.50%
BJDX	BLUEJAY DIAGNOSTICS INC	$3.72M	-125.00%	-99.80%	-77.20%	-1,294.50%	0.23	4.64	N/A	N/A	N/A
ASBP	ASPIRE-LAKEWOOD HOLDINGS INC	$11.47M	N/A	-181.30%	-14.68%	91.70%	0.15	7.99	-25.00%	-11,314.10%	-1,782.22%
TTRX	TURN THERAPEUTICS INC	$315.75M	-281.60%	-64.90%	-100.10%	-372.50%	23.69	1.19	N/A	N/A	N/A
FLNA	FILANA THERAPEUTICS INC	$35.89M	-58.80%	-36.70%	-66.33%	204.70%	0.63	2.09	N/A	N/A	N/A
PRME	PRIME MEDICINE INC	$602.17M	-188.30%	-59.10%	-86.45%	-58.20%	5.26	3.06	100.00%	-4,613.10%	-4,613.11%
AKTS	AKTIS ONCOLOGY INC	$925.51M	N/A	N/A	N/A	N/A	0.15	16.33	N/A	N/A	N/A
STXS	STEREOTAXIS INC	$106.21M	-203.60%	-45.50%	-77.55%	-190.10%	3.11	1.42	55.60%	-78.50%	-74.24%
HCWB	HCW BIOLOGICS INC	$2.31M	-639.50%	-85.10%	-57.91%	-47.90%	2.60	0.06	96.40%	-331.10%	-70.32%
PMN	PROMIS NEUROSCIENCES INC	$77.66M	-143.10%	-109.20%	-85.35%	825.20%	0.15	7.86	N/A	N/A	N/A
BLSM	BLOSSOMHILL THERAPEUTICS INC	$492.03M	N/A	N/A	N/A	N/A	-0.24	5.42	N/A	N/A	N/A
GLSI	GREENWICH LIFESCIENCES INC	$227.51M	-793.80%	-295.30%	-695.56%	470.30%	1.85	1.54	N/A	N/A	N/A
KRSA	KORSANA BIOSCIENCES INC	$21.17M	-88.00%	-74.90%	-131.85%	-145.20%	0.36	0.82	100.00%	-353.00%	-353.00%
MIRM	MIRUM PHARMACEUTICALS INC	$5.17B	-410.20%	-96.50%	-102.66%	-154.60%	-101.27	2.86	81.70%	-139.20%	-136.57%
AHCO	ADAPTHEALTH CORP	$863.06M	-15.20%	-5.20%	-3.83%	-4.70%	2.14	1.12	17.00%	-7.10%	-4.31%
MNKD	MANNKIND CORP	$980.70M	N/A	-6.30%	-0.03%	0.00%	-11.90	1.72	75.40%	-11.10%	-0.05%
DRTS	ALPHA TAU MEDICAL LTD	$1.27B	-138.10%	-81.70%	-107.57%	-125.50%	2.05	11.09	N/A	N/A	N/A
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$4.06B	-128.50%	-114.20%	-87.27%	-857.50%	0.10	10.77	N/A	N/A	N/A
LTGO	LATIGO BIOTHERAPEUTICS INC	$1.04B	N/A	N/A	N/A	N/A	-0.19	1.15	N/A	N/A	N/A
COYA	COYA THERAPEUTICS INC	$104.97M	-53.30%	-47.50%	-49.47%	3,005.10%	0.09	13.40	100.00%	-270.20%	-270.19%
HURA	TUHURA BIOSCIENCES INC	$115.35M	-154.30%	-107.00%	-131.17%	-328.20%	0.72	0.18	N/A	N/A	N/A
SLDB	SOLID BIOSCIENCES INC	$624.05M	-72.30%	-61.40%	-52.85%	-114.30%	0.12	13.82	N/A	N/A	N/A
IMDX	INSIGHT MOLECULAR DIAGNOSTICS INC	$97.85M	N/A	-141.50%	-257.14%	-1,223.30%	-2.38	2.00	48.30%	-2,955.60%	-2,949.76%
COGT	COGENT BIOSCIENCES INC	$4.87B	-72.60%	-48.70%	-47.98%	-53.60%	0.57	13.57	N/A	N/A	N/A
TPST	TEMPEST THERAPEUTICS INC	$10.88M	-1,270.10%	-297.40%	-780.86%	-299.80%	-9.84	0.38	N/A	N/A	N/A
EIKN	EIKON THERAPEUTICS INC	$363.99M	N/A	N/A	N/A	N/A	0.67	9.89	N/A	N/A	N/A
BNTX	BIONTECH SE	$22.51B	-9.10%	-8.00%	-8.60%	-18.40%	0.15	7.85	75.50%	-63.60%	-59.68%
CLYM	CLIMB BIO INC	$592.17M	-31.80%	-30.80%	-23.97%	-37.40%	0.03	31.45	N/A	N/A	N/A
GOSS	GOSSAMER BIO INC	$59.64M	N/A	-85.40%	187.72%	-58.40%	-1.82	0.53	100.00%	-235.00%	-214.60%
LITS	LITE STRATEGY INC	$36.79M	-97.30%	-95.90%	-170.94%	-109.30%	0.03	5.75	N/A	N/A	N/A
REPL	REPLIMUNE GROUP INC	$1.14B	-159.30%	-90.80%	-134.38%	-134.10%	1.39	5.23	N/A	N/A	N/A
DTIL	PRECISION BIOSCIENCES INC	$168.37M	-91.60%	-40.70%	-43.28%	-144.40%	1.78	12.82	100.00%	-117.00%	-114.11%
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$343.80M	-151.00%	-54.70%	-53.96%	-53.20%	4.47	8.26	99.50%	-186.30%	-172.51%
IONS	IONIS PHARMACEUTICALS INC	$7.04B	-110.90%	-17.40%	-17.64%	-11.60%	5.81	7.89	98.20%	-64.70%	-54.06%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$341.93M	-46.50%	-36.50%	-48.90%	-375.40%	0.31	5.88	100.00%	-317.60%	-317.64%
AKAN	AKANDA CORP	$1.08M	N/A	-806.90%	815.41%	-758.40%	-1.51	0.22	-12.00%	-7,703.80%	-7,443.07%
PEPG	PEPGEN INC	$173.15M	-51.00%	-43.50%	-54.28%	-69.90%	0.18	13.36	N/A	N/A	N/A
ALVO	ALVOTECH	$1.92B	N/A	-12.20%	10.08%	5.40%	-9.29	1.65	60.70%	-36.30%	25.61%
CRVO	CERVOMED INC	$34.32M	-156.00%	-128.30%	-132.18%	-408.30%	0.13	8.57	100.00%	-9,160.90%	-9,160.94%
JAGX	JAGUAR HEALTH INC	$1.43M	N/A	-131.50%	-401.61%	-277.10%	4.43	0.69	82.30%	-188.50%	-127.26%
IMUX	IMMUNIC INC	$94.01M	-157.90%	-107.90%	-87.22%	412.10%	0.25	5.05	N/A	N/A	N/A
RLAY	RELAY THERAPEUTICS INC	$3.80B	-42.30%	-38.70%	-31.20%	-46.90%	0.09	18.27	100.00%	-2,763.60%	-2,763.64%
QNTM	QUANTUM BIOPHARMA LTD	$21.90M	-417.20%	-184.20%	-409.47%	2,152.90%	1.04	1.20	N/A	N/A	N/A
KLRA	KAILERA THERAPEUTICS INC	$1.40B	N/A	N/A	N/A	N/A	0.08	11.11	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	605	-3.31%	-4.41%	-12.70%	-72.42%	14.11x	4.88x	-11.01%	-10.03%	-8.07%	+80.04%	Strong Buy
Diagnostics & Research	50	+0.10%	+0.57%	+9.91%	+27.17%	11.79x	4.71x	-29.33%	+5.36%	+11.40%	+2.64%	Buy
Drug Manufacturers - General	20	-1.75%	+0.62%	+1.14%	+24.37%	39.28x	7.83x	+23.62%	+10.74%	+19.12%	+25.37%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.97%	-0.73%	-5.30%	-94.19%	-1.74x	2.35x	-1.68%	+1.60%	+7.12%	+194.41%	Buy
Healthcare Plans	10	-0.24%	+3.91%	-0.88%	+18.01%	55.82x	2.32x	+10.70%	+3.28%	+8.15%	+11.54%	Buy
Health Information Services	50	-0.34%	-0.87%	+0.40%	-44.85%	11.95x	4.03x	+7.12%	+4.01%	+9.09%	+17.05%	Buy
Medical Care Facilities	48	-0.09%	+1.43%	-0.27%	-53.67%	16.80x	5.73x	-42.74%	+7.27%	+14.52%	+13.50%	Buy
Medical Devices	132	-0.38%	+0.33%	-1.59%	-95.34%	22.66x	3.06x	-9.45%	+5.29%	+9.68%	+27.22%	Strong Buy
Medical Distribution	8	+0.84%	+3.87%	+3.55%	+23.59%	26.62x	-190.64x	-76.01%	+4.11%	+24.39%	+6.81%	Buy
Medical Instruments & Supplies	50	-0.46%	+1.98%	+2.84%	+3.00%	44.54x	3.37x	+8.63%	+7.24%	+11.01%	+14.77%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Oct 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: A, Sentiment: C, Safety: C, Financials: A, and AI: B.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 21 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 91.3% over the past year, overperforming other healthcare stocks by 169 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -40.71% from Puma Biotechnology's current stock price of $10.12.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the #2 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bausch Health Companies (NYSE:BHC) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: C.

Bausch Health Companies (NYSE:BHC) has a Due Diligence Score of 6, which is -21 points lower than the healthcare sector average of 27. Although this number is below the industry average, our proven quant model rates BHC as a "A".It passed 2 out of 33 due diligence checks and has weak fundamentals. Bausch Health Companies has seen its stock lose -3.6% over the past year, overperforming other healthcare stocks by 74 percentage points.

Bausch Health Companies has an average 1 year price target of $9.00, an upside of 52.8% from Bausch Health Companies's current stock price of $5.89.

Bausch Health Companies stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Bausch Health Companies, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #3 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: B, Momentum: B, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 48, which is 21 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 106.39% over the past year, overperforming other healthcare stocks by 184 percentage points.

Bioventus has an average 1 year price target of $16.00, an upside of 17.99% from Bioventus's current stock price of $13.56.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 79 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Conmed (NYSE:CNMD)

Conmed (NYSE:CNMD) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.25%. Conmed's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Conmed's dividend has not shown consistent growth over the last 10 years.

Conmed's dividend payout ratio of 10.8% indicates that its dividend yield is sustainable for the long-term.

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals (NASDAQ:CPIX) has an annual dividend yield of 20.92%, which is 19 percentage points higher than the healthcare sector average of 2.25%.

Cumberland Pharmaceuticals's dividend payout ratio of -411% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.52%, which is 9 percentage points higher than the healthcare sector average of 2.25%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 207.9% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -1.35% in the last day, and down -0.79% over the last week. Syndax Pharmaceuticals was the among the top losers in the healthcare sector, dropping -15.71% yesterday.

Syndax Pharmaceuticals shares are trading lower after the company announced that the MAXPIRe Phase 2 trial of axatilimab in idiopathic pulmonary fibrosis did not meet its primary endpoint of the annualized rate of decline in forced vital capacity.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 142.57% in the past year. It has overperformed other stocks in the healthcare sector by 220 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 55.68% in the past year. It has overperformed other stocks in the healthcare sector by 133 percentage points.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -53.56% in the past year. It has overperformed other stocks in the healthcare sector by 24 percentage points.

Are healthcare stocks a good buy now?

59.17% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.26% over the next year.

4.04% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.26% of healthcare stocks are rated B (Buy), 48.61% are rated C (Hold), 27.4% are rated D (Sell), and 6.69% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 30.08x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Bausch Health Companies (NYSE:BHC)

3. Bioventus (NASDAQ:BVS)

1. Conmed (NYSE:CNMD)

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Embecta (NASDAQ:EMBC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Bausch Health Companies (NYSE:BHC)

3. Bioventus (NASDAQ:BVS)

1. Conmed (NYSE:CNMD)

2. Cumberland Pharmaceuticals (NASDAQ:CPIX)

3. Spok Holdings (NASDAQ:SPOK)

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Embecta (NASDAQ:EMBC)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.